Clinical trial
Prevention of Atrial Fibrillation by the Prescription of Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter
NCT00736294 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Saint Etienne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Atrial Fibrillation by the Prescription of Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter
- Lead sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- July 31, 2008
- Completion date
- March 31, 2015
- Enrollment
- 198 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.